Cardiovascular thrombotic events in arthritis trials of the cyclooxygenase-2 inhibitor celecoxib

By White W.B.   Faich G.   Borer J.S.   Makuch R.W.  

ACC Current Journal Review, Vol. 12, Iss. 6, 2003-11 ,pp. : 14-15

Elsevier

Access to resources Recommend Favorite

Tolerability of Selective Cyclooxygenase Inhibitor, Celecoxib, in Patients with Analgesic Intolerance

By Çelik Gülfem   Paşaoğlu Gülden   Bavbek Sevim   Abadoğlu Öznur   Dursun Berna   Mungan Dilşad   Mısırlıgil Zeynep  

Journal of Asthma, Vol. 42, Iss. 2, 2004-03 ,pp. : 127-131

Informa Healthcare

Access to resources Recommend Favorite

Pneumocystis jirovecii pneumonia: a rare but serious complication during TNF inhibitor treatment for rheumatoid arthritis in Japan

By Miyasaka Nobuyuki   Harigai Masayoshi  

International Journal of Clinical Rheumatology, Vol. 8, Iss. 4, 2013-08 ,pp. : 425-426

Future Medicine

Access to resources Recommend Favorite

Effects of selective and non-selective cyclo-oxygenase inhibition on endothelial function in patients with rheumatoid arthritis

By Wong M.   Jiang B. Y.   McNeill K.   Farish S.   Kirkham B.   Chowienczyk P.  

Scandinavian Journal of Rheumatology, Vol. 36, Iss. 4, 2007-01 ,pp. : 265-269

Informa Healthcare

Access to resources Recommend Favorite

Efficacy and safety of tacrolimus in 101 consecutive patients with rheumatoid arthritis

By Kitahama Mariko   Okamoto Hiroshi   Koseki Yumi   Inoue Eisuke   Kaneko Hirotaka   Taniguchi Atsushi   Momohara Shigeki   Yamanaka Hisashi  

Modern Rheumatology, Vol. 20, Iss. 5, 2010-10 ,pp. : 478-485

Springer Publishing Company

Access to resources Recommend Favorite